Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hideaki Kinugasa
Switching Between Three Types of Mesalazine Formulation and Sulfasalazine in Patients With Active Ulcerative Colitis Who Have Already Received High-Dose Treatment With These Agents
Journal of Clinical Medicine
Related publications
Oral High Dose Beclomethasone Dipropionate for Treatment of Active Ulcerative Colitis
Gastroenterology Insights
Hepatology
Gastroenterology
Systematic Review: Safety of Mesalazine in Ulcerative Colitis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Differential Expression of MUC12, MUC16, and MUC20 in Patients With Active and Remission Ulcerative Colitis
Mediators of Inflammation
Immunology
Cell Biology
IBS-like Symptoms in Patients With Ulcerative Colitis
Clinical and Experimental Gastroenterology
Gastroenterology
Correlation of Fecal Markers With Magnifying Endoscopic Stratification in Patients With Ulcerative Colitis Who Are in Clinical Remission
Digestion
Gastroenterology
Sulfasalazine Pulmonary Toxicity in Ulcerative Colitis Mimicking Clinical Features of Wegener's Granulomatosis
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Psy100 - Cost-Effectiveness Analysis of Second Line Treatment for Patients With Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Editorial: Mesalazine and Mucosal Microbiome in Quiescent Ulcerative Colitis-What Can We Learn?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
